153 related articles for article (PubMed ID: 20886266)
1. Influence of temperature on solvent-mediated anhydrate-to-hydrate transformation kinetics.
Qu H; Munk T; Cornett C; Wu JX; Bøtker JP; Christensen LP; Rantanen J; Tian F
Pharm Res; 2011 Feb; 28(2):364-73. PubMed ID: 20886266
[TBL] [Abstract][Full Text] [Related]
2. Solubility and stability of anhydrate/hydrate in solvent mixtures.
Qu H; Louhi-Kultanen M; Kallas J
Int J Pharm; 2006 Sep; 321(1-2):101-7. PubMed ID: 16784825
[TBL] [Abstract][Full Text] [Related]
3. Determination of hydrate transition temperature using transformation kinetics obtained by Raman spectroscopy.
Wikström H; Kakidas C; Taylor LS
J Pharm Biomed Anal; 2009 Feb; 49(2):247-52. PubMed ID: 19112003
[TBL] [Abstract][Full Text] [Related]
4. Physical stability of crystal hydrates and their anhydrates in the presence of excipients.
Salameh AK; Taylor LS
J Pharm Sci; 2006 Feb; 95(2):446-61. PubMed ID: 16380975
[TBL] [Abstract][Full Text] [Related]
5. Identification of phase boundaries in anhydrate/hydrate systems.
Krzyzaniak JF; Williams GR; Ni N
J Pharm Sci; 2007 May; 96(5):1270-81. PubMed ID: 17455300
[TBL] [Abstract][Full Text] [Related]
6. Drug hydrate systems and dehydration processes studied by terahertz pulsed spectroscopy.
Zeitler JA; Kogermann K; Rantanen J; Rades T; Taday PF; Pepper M; Aaltonen J; Strachan CJ
Int J Pharm; 2007 Apr; 334(1-2):78-84. PubMed ID: 17129691
[TBL] [Abstract][Full Text] [Related]
7. Manipulating theophylline monohydrate formation during high-shear wet granulation through improved understanding of the role of pharmaceutical excipients.
Wikström H; Carroll WJ; Taylor LS
Pharm Res; 2008 Apr; 25(4):923-35. PubMed ID: 17896097
[TBL] [Abstract][Full Text] [Related]
8. Probing pseudopolymorphic transitions in pharmaceutical solids using Raman spectroscopy: hydration and dehydration of theophylline.
Amado AM; Nolasco MM; Ribeiro-Claro PJ
J Pharm Sci; 2007 May; 96(5):1366-79. PubMed ID: 17455358
[TBL] [Abstract][Full Text] [Related]
9. Crystallization of a polymorphic hydrate system.
Tian F; Qu H; Louhi-Kultanen M; Rantanen J
J Pharm Sci; 2010 Feb; 99(2):753-63. PubMed ID: 19569226
[TBL] [Abstract][Full Text] [Related]
10. Visualizing solvent mediated phase transformation behavior of carbamazepine polymorphs by principal component analysis.
Tian F; Rades T; Sandler N
AAPS PharmSciTech; 2008; 9(2):390-4. PubMed ID: 18431672
[TBL] [Abstract][Full Text] [Related]
11. Calorimetric investigation of solvent-mediated transformation of sulfamerazine polymorphism.
Kawakami K; Asami Y; Takenoshita I
J Pharm Sci; 2010 Jan; 99(1):76-81. PubMed ID: 19718749
[TBL] [Abstract][Full Text] [Related]
12. Anhydrate to hydrate solid-state transformations of carbamazepine and nitrofurantoin in biorelevant media studied in situ using time-resolved synchrotron X-ray diffraction.
Boetker JP; Rantanen J; Arnfast L; Doreth M; Raijada D; Loebmann K; Madsen C; Khan J; Rades T; Müllertz A; Hawley A; Thomas D; Boyd BJ
Eur J Pharm Biopharm; 2016 Mar; 100():119-27. PubMed ID: 26774635
[TBL] [Abstract][Full Text] [Related]
13. Crystallization pathways and kinetics of carbamazepine-nicotinamide cocrystals from the amorphous state by in situ thermomicroscopy, spectroscopy, and calorimetry studies.
Seefeldt K; Miller J; Alvarez-Núñez F; Rodríguez-Hornedo N
J Pharm Sci; 2007 May; 96(5):1147-58. PubMed ID: 17455346
[TBL] [Abstract][Full Text] [Related]
14. Influence of the solid form of siramesine hydrochloride on its behavior in aqueous environments.
Zimmermann A; Tian F; Lopez de Diego H; Ringkjøbing Elema M; Rantanen J; Müllertz A; Hovgaard L
Pharm Res; 2009 Apr; 26(4):846-54. PubMed ID: 19005740
[TBL] [Abstract][Full Text] [Related]
15. Qualitative in situ analysis of multiple solid-state forms using spectroscopy and partial least squares discriminant modeling.
Kogermann K; Aaltonen J; Strachan CJ; Pöllänen K; Veski P; Heinämäki J; Yliruusi J; Rantanen J
J Pharm Sci; 2007 Jul; 96(7):1802-20. PubMed ID: 17253647
[TBL] [Abstract][Full Text] [Related]
16. Solvent-mediated solid phase transformations of carbamazepine: Effects of simulated intestinal fluid and fasted state simulated intestinal fluid.
Lehto P; Aaltonen J; Tenho M; Rantanen J; Hirvonen J; Tanninen VP; Peltonen L
J Pharm Sci; 2009 Mar; 98(3):985-96. PubMed ID: 18661533
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous measurement of liquid-phase and solid-phase transformation kinetics in rotating disc and channel flow cell dissolution devices.
Lehto P; Aaltonen J; Niemelä P; Rantanen J; Hirvonen J; Tanninen VP; Peltonen L
Int J Pharm; 2008 Nov; 363(1-2):66-72. PubMed ID: 18675891
[TBL] [Abstract][Full Text] [Related]
18. Kinetic study on hemipenta hydrate risedronate monosodium in batch crystallization by cooling mode.
Nguyen TN; Kim KJ
Int J Pharm; 2008 Nov; 364(1):1-8. PubMed ID: 18582549
[TBL] [Abstract][Full Text] [Related]
19. Miniaturized X-ray powder diffraction assay (MixRay) for quantitative kinetic analysis of solvent-mediated phase transformations in pharmaceutics.
Kirchmeyer W; Grassmann O; Wyttenbach N; Alsenz J; Kuentz M
J Pharm Biomed Anal; 2016 Nov; 131():195-201. PubMed ID: 27596832
[TBL] [Abstract][Full Text] [Related]
20. Phase transformations of amlodipine besylate solid forms.
Koradia V; de Lemos AF; Allesø M; de Diego HL; Ringkjøbing-Elema M; Müllertz A; Rantanen J
J Pharm Sci; 2011 Jul; 100(7):2896-910. PubMed ID: 21344410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
